Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer—A population‐based cohort study

by Rano Matta, Amanda E. Hird, Erind Dvorani, Refik Saskin, Gregory J. Nason, Girish Kulkarni, Ronald T. Kodama, Sender Herschorn, Robert K. Nam
Published 2020-10-01

Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis

by Christopher J. D. Wallis MD, Gerard Morton MD, Angela Jerath MD, Raj Satkunasviam MD, Ewa Szumacher MD, Sender Herschorn MD, Ronald T. Kodama MD, Girish S. Kulkarni MD, David Naimark MD, Robert K. Nam MD
Published 2017-05-01

Blood-based biomarkers of aggressive prostate cancer.

by Men Long Liong, Chun Ren Lim, Hengxuan Yang, Samuel Chao, Chin Wei Bong, Wing Seng Leong, Prashanta Kumar Das, Chit Sin Loh, Ban Eng Lau, Choon Geok Yu, Edie Jian Jiek Ooi, Robert K Nam, Paul D Allen, Graeme S Steele, Karl Wassmann, Jerome P Richie, Choong Chin Liew
Published 2012-01-01